This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Astrazeneca Ab. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Sofia Ferrer Cabrera: Innovator in Cancer Treatment
Introduction
Sofia Ferrer Cabrera is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds.
Latest Patents
Sofia holds a patent for POLQ inhibitors, which are compounds that inhibit the polymerase, DNA polymerase theta (Polθ or POLQ). The specification generally relates to compounds of Formula (I) or a stereoisomer or pharmaceutically acceptable salt thereof. These compounds are particularly useful in the treatment of cancer, showcasing her commitment to advancing medical science. She has 1 patent to her name.
Career Highlights
Sofia is currently employed at AstraZeneca AB, where she continues to work on groundbreaking research in the pharmaceutical industry. Her role at such a prestigious company highlights her expertise and dedication to improving therapeutic options for patients.
Collaborations
Throughout her career, Sofia has collaborated with notable colleagues, including Oliver Turner and Helen Elizabeth Jones. These partnerships have further enriched her research and contributed to the success of her projects.
Conclusion
Sofia Ferrer Cabrera is a trailblazer in the field of cancer treatment, with her innovative work on POLQ inhibitors paving the way for new therapeutic strategies. Her contributions to the pharmaceutical industry are invaluable and continue to inspire future advancements in medical research.